Base-based Azotation Modification Service

Applications of Azotation in Structural Modification

Nitrogen atoms are important elements in bases that can be introduced, replaced, or modified to change the nature and function of the nucleoside. Azotation modification involves a series of chemical reactions, including the introduction of amino groups, carbamate groups, nitro groups, etc., to bases. In nucleoside modification, azotation is commonly used to introduce amino groups. For example, using nitrite or other nitrogen-containing reagents to react with it to cause a substitution reaction, an amino group is introduced into the molecule to form the corresponding amino-modified products. This modification method has an important application value in abiotic synthesis and can be used to synthesize a variety of nucleosides and nucleotide derivatives with specific functions or properties to meet the needs of drug discovery and development, chemical biology research, and materials science. It meets the needs of drug discovery, chemical biology research, and materials science.

Different types of natural nucleosides that constitute nucleic acids.Fig.1 Different types of natural nucleosides that constitute nucleic acids. (Baroud, et al., 2021)

Base-based Azotation Modification Service at CD BioGlyco

CD BioGlyco specializes in the field of Nucleoside & Nucleotide Modification and provides high-quality base-based HalogenationN-conjugation, and azotation modification services. Through azotation reactions, we introduce nitrogen groups to realize changes in their structure and function. The specific azotation modification services we offer include the following:

  • Under alkaline conditions, we react electrophilic nitroso reagents such as nitrites or nitrosamines with nucleosides or nucleotides. It is modified by the substitution reaction of the electrophilic nitroso reagent with the nitrogen-containing basic site.
  • We use some metal catalysts, such as palladium or copper catalysts, to induce the reaction of C-H bonds in nucleosides with a nitrogen source to form new C-N bonds. This improves the selectivity and reactivity of the modification and can be performed under mild reaction conditions.
  • It is modified by reaction with a nucleophilic reagent, such as an amine, in which the amino group in the nucleoside or nucleotide is replaced by a new amine compound.

Flow chart of our service.Fig.2 Flow chart of our service. (CD BioGlyco)

Applications

  • The technology of nucleotide modification has the potential to enhance the biological activity of small molecules in drug discovery, helping developers to optimize the performance of drug candidates.
  • Nucleotide modification techniques can be used for genome sequencing and disease detection.
  • Nucleotide modification technologies have promising applications in screening for genetic diseases. By modification of nucleotide sequences, individuals carrying specific genetic mutations can be identified.

Advantages of Us

  • Our team members have a wide range of academic backgrounds and professional experience, covering a wide range of areas of knowledge and skills.
  • We offer the best customized modification strategies and flexible service models so that clients can choose the most appropriate solutions and services according to their needs.
  • We are committed to completing projects efficiently, doing our best to meet client timelines, and ensuring that deliverables are of high quality.

At CD BioGlyco, our dedicated team ensures that base-based azotation modification is done efficiently and reliably by utilizing our state-of-the-art Glyco™ Synthesis Platform and designing suitable solutions according to the client's needs. Our services will help you expand the chemical diversity of nucleosides and nucleotides, opening up more possibilities for your research and development. If you are interested in our services, please feel free to contact us for more details.

Reference

  1. Baroud, M.; et al. The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery. Nanoscale Advances. 2021, 3(8): 2157-2179.
This service is for Research Use Only, not intended for any clinical use.

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0